Dynamin Is Required for Recombinant Adeno-Associated Virus Type 2 Infection

Recombinant adeno-associated virus (rAAV) vectors for gene therapy of inherited disorders have demonstrated considerable potential for molecular medicine. Recent identification of the viral receptor and coreceptors for AAV type 2 (AAV-2) has begun to explain why certain organs may demonstrate higher...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Duan, Dongsheng, Li, Qiang, Kao, Aimee W., Yue, Yongping, Pessin, Jeffrey E., Engelhardt, John F.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1999
Assuntos:	Gene Therapy
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC113092/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10559355/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.73.12.10371-10376.1999
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!